In gastric cancer, increased levels of Gal-1 have been associated with lower overall and disease-free survival, as well as with an increased incidence of lymph node metastasis in patients [154–156]. This evidence concerns the gene LGALS1 and metastatic malignant neoplasm in the lymph nodes.